OCC Commends FDA for Second Obesity Medication Approval

Obesity Care Continuum (OCC) Commends Food and Drug Administration (FDA) for their Continued Proactive Support and Approval of New Obesity Treatments

Washington, DC – Today, members of the Obesity Care Continuum (OCC) commended the Food and Drug Administration (FDA) for their continued proactive approach to ensuring safe obesity treatment options for the more than 93 million Americans affected by the disease…

To view the full news release, click here.



Leave a Reply



© 2014 Obesity Action Coalition 4511 North Himes Avenue • Suite 250 • Tampa, Florida 33614 • (800) 717-3117